SECUGEN SL

SECUGEN is a biotechnology company specialized in automatic DNA sequencing and genetic analysis applied to any life sciences discipline. Its objective is to support professionals in this sector and continue with research and collaboration on new projects.

• ACTIVITY: genetic analysis.
• LOCATION: Calle Ramiro de Maeztu 9 (28040) Madrid.
• CONSTITUTION DATE: 2005.
• CATEGORY: small business.
• CONTACT: (+34) 915 338 628

• N

• NUMBER OF EMPLOYEES: 12.
• INCOME: ~1.000.000 €
• GENERAL DESCRIPTION: company specialized in DNA sequencing and analysis and its application to any area of life sciences.
• BUSINESS LINES: sDNA sequencing, genetic diagnosis, R&D services.
• INFRASTRUCTURE: 
  • Services:
    • DNA sequencing.
    • Analysis of microsatellites and fragments.
    • DNA purification.
    • Genetic and molecular diagnosis.
    •  Microbial identification, varietal identification, species authentication.
    • Analysis by q-PCR.
    • Analysis by immunoassay (ELISA and CLIA).
    • R&D services.

TECHNOLOGICAL SUPPLY/DEMAND:

• Development of custom projects.
• Experience in DNA analysis as a genetic marker.
• Great sample processing capacity.

COMPLETED PROJECTS

• Development of a kit for the diagnosis of mutations and polymorphisms in the human mitochondrial genome. Biotec Cam. 2006-2007 / Community of Madrid.
• Development of a high-performance diagnostic system for the detection of mutations and polymorphisms associated with age-related macular degeneration. Profit 2007-2007 / Ministry of Education and Science.
• Development of a high-performance diagnostic system for the detection of mutations and polymorphisms associated with non-syndromic human deafness. Biotec Cam. 2007-2008 / Community of Madrid.
• The microbial metagenome of the iberian peninsula. Consolider 2007-2011 / Ministry of Science and Innovation.
• Development and proof of concept of a high-performance diagnostic system for the detection of mutations and polymorphisms associated with age-related macular degeneration. Biotec Cam. 2008-2008 / Community of Madrid.
• Development of new DNA polymerases for amplification, modification and genetic analysis of DNA. Impact 2016-2019 / Ministry of Science and Innovation.
• Integrated platform for the molecular diagnosis of diseases related to the complement system. Challenges 2016-2019 / European Union and Ministry of Economy, Industry and Competitiveness.